We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · February 17, 2021

Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-Term Responders

Ophthalmology Retina

 

Additional Info

Ophthalmology Retina
Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-Term Responders: A Prospective Spectral-Domain OCT Study
Ophthalmol Retina 2020 Dec 01;4(12)1138-1145, G Bontzos, S Bagheri, L Ioanidi, I Kim, I Datseris, E Gragoudas, S Kabanarou, J Miller, M Tsilimbaris, DG Vavvas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading